je.st
news
Report: J&J close to deal to buy partner Pharmacyclics
2015-03-05 03:32:17| Food - Topix.net
Health care giant Johnson & Johnson reportedly is close to buying biopharmaceutical company Pharmacyclics, its longtime partner in developing blood cancer treatment Imbruvica. London's Financial Times reports "people familiar with the matter" say Johnson & Johnson's anticipated offer would value Pharmacyclics of Sunnyvale, California, above its current $17 billion market capitalization.
Tags: report
buy
close
partner
Category:Food and Related Products
Latest from this category |
All news |
||||||||||||||||||||
|
|